Our Action Packed Agenda

Pre-order the Latest Brochure

Medicine is just the beginning

    • Keynotes
Partner your way to a real solution
    • Keynotes
  • What’s your partnership & acquisition strategy? How to identify the organisations that will take your offerings to a completely different level
The new battlegrounds are not where you expect
    • Keynotes
  • Why manufacturing and supply chain will be the key differentiator as direct-to-patient supply and admin are the success factors for personalised, biological and specialised medicines
  • Why the huge gains to be made in African women’s health will reposition your entire business and determine pharma’s narrative
  • Prevention is better than cure: why prophylactic treatments, gene and cell therapies and genomics are priority areas for investment today
UCB’s next step: Become non-patient centric
    • Keynotes
  • Recognise that healthcare is expanding – because we all spend more on preventing sickness.
  • How UCB is planning for the ‘swing factor’ when we eventually shift to working with those who are not patients to prevent their need for acute healthcare
The Authenticity Factor: how CMOs can pioneer rapid-reaction strategy based on continuous data input
    • Keynotes
  • Hear the argument for re-centralisation of medical teams in order to create a core of medical expertise
  • Determine to what degree medical and commercial must align – and how to empower them with high-grade datasets
How the Otsuka-Proteus collaboration has invented digital therapeutics as a new drug category
    • Keynotes
  • Witness how a shared commitment to address non-adherence in mental illness has created an edible, microscopic communication platform, approved by the FDA
  • How the connection of hardware (as a medicine) and software has resulted in new product categories with a range of capabilities
Let the health entrepreneurs show you how
    • Keynotes
  • Witness elevator pitches from 6 hand-selected healthcare startups who promise to disrupt pharma – and who could be your next partner
  • Understand the true risk, ambition and what is possible with minimal resources
Your agility ability: why adopting more iterative and experimental innovation techniques need a new type of learning culture
    • Keynotes
  • Why your revenue-focussed objectives will fail in an entrepreneurial environment
  • Ways you can create faster, more experimental innovation without sacrificing safety and reliability
We fight for the patient – and the patient fights for us
    • Keynotes
  • How the smartest companies are able to go beyond empowerment, beyond advocacy and work with patients for sustained access in a virtuous circle
  • Why your goal must be to have the most comprehensive patient insights if you are ever going to gain trusted partner status

The Revolution is here

    • Commercial
An end-to-end view to your customer suite
    • Commercial
  • Adopt a multi-customer model: Physicians, Payers, Policy Makers and Patients. Integrated multi-customer strategies are the way forward.
Sandoz Case Study: Commercial Excellence: as strong as the weakest link
    • Commercial
  • Case Study: Commercial Excellence: as strong as the weakest link
  • Understand the end-to-end process and understand that customer centricity as the key lighthouse and everything you need to do to ensure you meet the expected customer experience.
Determine which analytical and data resources will enable the evolution of your commercial department
    • Commercial
  • Streamline commercial activities by selecting and driving the right kind of input data

Redefine your salesforce

    • Commercial
It's not the size that matters; it's what you do with it
    • Commercial
  • Create a rapid-reaction, data-driven sales force which delivers maximum impact with minimal resources
Case study: enable reps and MSLs to deliver more immersive education with VR tools
    • Commercial
  • How VR can change the way educational content is delivered for a more in-depth learning experience
The digitally mature sales function: how you can transform sales reps into catalysts
    • Commercial
  • How real digital transformation will be dependent on capabilities of your customer-facing teams

Be more than just a partner

    • Digital
Achieve personalization through Omni-channel, longitudinal & behavioral analysis.
    • Digital
  • Establish an Omni-channel customer view, understand customer decision journeys
  • Observe customer behaviors gather insights on all the above over short campaign iterations
Customer Experience: how to design an intentional customer journey that resonates at every step
    • Digital
  • Plan the journey and action you want your customers to take and find the moments that you can move the needle

Change the nature of the conversation

    • Digital
Smarter and more personalised content as the driver of authenticity and authority
    • Digital
  • Co-create content in partnership with customers and find ways to make it more specific
Lessons learned: how GSK's educational virtual meetings have affected HCP engagement
    • Digital
  • Get a behind-the-scenes look at whether the GSK sales paradigm and new ecosystem has translated into results

Redefine your business

    • Digital
Start with the service to go beyond just 'beyond the pill'
    • Digital
  • Understand how true value can be translated from the patient rather than from the medicine or treatment regimen
Real advocacy - how to become your patient organisation's number one partner
    • Digital
  • Innovate at the cutting edge of patient communication to generate fans, not just advocates

Gain traction and harness technology

    • Digital
The digitally mature sales function: how you can transform sales reps into catalysts
    • Digital
  • How real digital transformation will be dependent on capabilities of your customer-facing teams
Understand how the latest in marketing automation and CRM tech can provide a new communication paradigm
    • Digital
  • How automation of key marketing processes can lift your ability to create bespoke interactions

Genuine Patient Centricity through collaboration

    • Patient
From competitors to collaborators - form alliances in the interest of the patient
    • Patient
  • Stop creating your own platforms - co-create the one platform that patients admire
Patient perspectives on the good, the bad and the ugly of service design
    • Patient
  • We talk of innovation, but where do patients really see the opportunity for change?
AbbVie case study: Crush Your FOFO – empowering a nation to take control of its health
    • Patient
  • Hear how AbbVie is collaborating with experts from outside the health industry in a bold preventative health move
  • AbbVie will explore the value of leveraging real-life, data-driven insights to further understand complex human behaviour, in order to ultimately help build a more sustainable NHS.

Patient Experience for Patient Centricity

    • Patient
Real advocacy - how to become your patient organisation's number one partner
    • Patient
  • Innovate at the cutting edge of patient communication to generate fans, not just advocates
Convince skeptics and prove the commercial value of a patient-centric approach
    • Patient
  • Obtain senior-level support for patient initiatives by linking efforts to outcomes

Support Patients from start to finish

    • Patient
Shape the business landscape
    • Patient
  • Learn how anticipation of policy changes and proactive engagement on advocacy and policy shaping can be a critical source of competitive advantage.
Start with the service to go beyond just 'beyond the pill'
    • Patient
  • Understand how true value can be translated from the patient rather than from the medicine or treatment regimen
Drive winning Patient Support Programmes (PSPs) with health psychology and behavioural science
    • Patient
  • Create better programme designs that incorporate multichannel, continuous, personalised support

Take health stakeholder partnerships to the next level

    • Patient
Educate payers on the value of your patient insights and their impact
    • Patient
  • How to articulate new patient journeys to make it straightforward for payers to model their long-term budgets
How new digital tools add extra fidelity to the quality of your RWD
    • Patient
  • Analyse PROs with data mining tools, gain depth with always-on and wearable source inputs, experience new forms of data
Personalised patient services as your key differentiator and performance enabler
    • Patient
  • Use more granular data to provide flexiblity and better value in your service provision for patients

Redefine medical strength

    • Medical Affairs
Panel: Medical as leader: see how a centralised medical function can improve dynamics with HCPs
    • Medical Affairs
  • See whether a concentrated medical HQ team can advance the treatment of disease and lay stronger foundations for commercial
Beyond education: become a source of inspiration for HCPs
    • Medical Affairs
  • Give HCPs revealing insights about patient populations and enable them to provide real service to patients
Help drive R&D innovation with more meaningful patient & real-world insights
    • Medical Affairs
  • Understand when and where medical’s scientific leadership can be successfully incorporated into the development paradigm

Increase field force effectiveness

    • Medical Affairs
Remove complexity with smarter KAM and MSL coordination
    • Medical Affairs
  • Target influencers with smart segmentation and influential messaging
Determine newly appropriate metrics to drive your MSL team into new territory
    • Medical Affairs
  • Gain cohesiveness, transparency and performance with widely-supported new targets for medical

Achieve digital excellence

    • Medical Affairs
Lessons learned: how GSK's educational virtual meetings have affected HCP engagement
    • Medical Affairs
  • Get a behind-the-scenes look at whether the GSK sales paradigm and new ecosystem has translated into results
Smarter and more personalised content as the driver of authenticity and authority
    • Medical Affairs
  • Co-create content in partnership with customers and find ways to make it more specific

Carry the patient voice internally

    • Medical Affairs
Personalised patient services as your key differentiator and performance enabler
    • Medical Affairs
  • Use more granular data to provide flexibility and better value in your service provision for patients
Real advocacy - how to become your patient organisation's number one partner
    • Medical Affairs
  • Innovate at the cutting edge of patient communication to generate fans, not just advocates
The ‘Fake News’ crisis is hurting patients: here’s how we fix It
    • Medical Affairs
  • Understand the undue influence of inaccurate health information and ensure your materials support the right answers

Make patient value priority

    • Market Access
Educate payers on the value of your patient insights and their impact
    • Market Access
  • How to articulate new patient journeys to make it straightforward for payers to model their long-term budgets
Start with the service to go beyond just 'beyond the pill'
    • Market Access
  • Understand how true value can be translated from the patient rather than from the medicine or treatment regimen

Pricing innovation

    • Market Access
Achieve the best price for specialty drugs through innovative payment models
    • Market Access
  • See how fully curative or restorative treatments can be funded despite their high initial budget impact
Stronger value-based contracting: use best-in-class predictive analytics
    • Market Access
  • Forecast commercial performance by establishing value benchmarks and data quality from the outset

Find stakeholder harmony

    • Market Access
How to work more openly with HTAs to support uptake and improve patient care
    • Market Access
  • Why more transparent working in partnership with government may be a worthy pursuit
Understand the future of early access to support your long-term commercial performance
    • Market Access
  • Determine the appropriate criteria to temper your investment in early access schemes

Catalyse trust in RWE

    • Data & RWE
Pharma’s role in building a robust European healthcare data-scape
    • Data & RWE
  • See a recap on the IMI’s collaborative efforts in building the stakeholder groundwork to ensure data standards meet decision-altering requirements
  • The next steps in breaking down data silos to reach the full potential of RWE insight
Stakeholder Panel: Understand the acceptability of RWE across global regulatory decision-making
    • Data & RWE
  • Explore the evolving role of RWE in the evidence lifecycle, quality expectations and the possibility of regulatory grade RWE
  • Discuss the impact of regulatory policies, such as 21st Century Cures Act, on the global adoption of RWD into R&D and Access framework

Create your data symphony

    • Data & RWE
The quest for harmony: understand the data standardisation timeline for BD4BO, EMIF and new EHDN initiatives
    • Data & RWE
  • An essential update on progress and the further ambitions of transformational public European initiatives
Case Study: More data, less patients: the digital opportunity
    • Data & RWE
  • Understand how Novartis are creating new digital endpoints in phase III to gain greater disease understanding, whilst reducing patient impact

Reimagine R&D with RWE

    • Data & RWE
Case Study: Modernise the development paradigm with RWE
    • Data & RWE
  • Explore how Flatiron/Roche are advancing medical research, using technology to increase the credibility of EHRs
  • Discuss the implications “contemporary” control arms maybe have on traditional development processes
Panel: Understand how to prove real-world effectiveness pre-launch
    • Data & RWE
  • Case Study: Explore how phase II of the IMI GetReal programme is developing industry-wide standards and methodologies to accelerate adoption of RWE
  • Discuss how to incorporate RWE into the traditional R&D framework and tools available now to enhance operational efforts

RWE driven Market Access

    • Data & RWE
Understand how RWE assessment fits into different HTA assessment methodologies across Europe
    • Data & RWE
  • Bring it home: use local affiliates to feed into international RWE and access planning
  • Compare and contrast the range of HTA evidence hierarchies across Europe
Stronger value-based contracting: use best-in-class predictive analytics
    • Data & RWE
  • Forecast commercial performance by establishing value benchmarks and data quality from the outset
Determine whether you can pursue personalised reimbursement with better data and insights
    • Data & RWE
  • See how a payment-for-individual-results model could be implemented and favoured by payers
Day 2 to go here...
Day 3 to go here...